Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomised, Open Label Study Comparing a "Scheduled Steroid Reduction Strategy" Versus a Free Steroid Reduction Strategy (Physician's Usual Practice for Reducing Steroids) in Patients With Active RA Treated With Humira 40 mg Eow + MTX During 9 Months

NCT00233558 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00233558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomised, Open Label Study Comparing a "Scheduled Steroid Reduction Strategy" Versus a Free Steroid Reduction Strategy (Physician's Usual Practice for Reducing Steroids) in Patients With Active RA Treated With Humira 40 mg Eow + MTX During 9 Months
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2005
Completion date
Not reported
Enrollment
160
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis